Peripheral Nerve Stimulators Market Expected To Witness Sublimation With A CAGR Of 7.3% Between 2028
Growing incidences of nerve injuries and increase in obese population causing neurodegenerative disorders are two critical factors driving the demand for peripheral nerve stimulators.
Demand for peripheral nerve stimulators is expected to grow further given the high applicability through anesthesia procedures and in severe neuropathic pain.
Peripheral nerve stimulators being a targeted pain relief treatment allowing patients to take fewer pain medications indicates promising opportunities in the near future, specifically associated with pain management technologies.
With the Food and Drug Administration (FDA) recently clearing two neurostimulation devices- SPRINT endura and extensa, for treating acute and chronic pain, the future landscape for peripheral nerve stimulators (PNS) looks promising.
Get Going With Sample Of Peripheral Nerve Stimulators Market Report! https://www.persistencemarketresearch.com/samples/18982
Boston Scientific Corporation
Medline Industries, In
SPR Therapeutics LLC
As per a recently released in-depth study by Persistence Market Research (PMR), the global peripheral nerve stimulator market is projected to represent a robust year on year revenue growth of approximately 6.9 percent in 2019. The global peripheral nerve stimulator market is expected to reach a valuation of US$ 375.9 Million, during the same period.
In addition, current advancements in the peripheral nerve stimulators would gradually increase the demand for treating a host of chronic pain conditions arising from cranial neuralgias and peripheral nerve dysfunctions.
Apart from their implantation being minimally invasive, the new variants of peripheral nerve stimulators also allow externally-placed pulse generators to wirelessly transmit impulses to the implanted electrode.
Moreover, miniaturization of neuromodulation devices and ultrasound-guided, minimally invasive implantation technique are some notable advancements, likely to shift the spotlight on non-drug pain management solutions, such as peripheral nerve stimulators.
How About Re-Inventing The Methodical Wheel In The Peripheral Nerve Stimulators Market? Switch Over To The "Methodology" Tab! https://www.persistencemarketresearch.com/methodology/18982
Insights from Segmentation Analysis of Peripheral Nerve Stimulator Market
Regionally, Europe with anticipated market share of approximately 35 percent by 2028-end, followed by North America accounting for 33.6 percent, for the same period will remain the most lucrative market for peripheral nerve stimulators.
By the type of peripheral nerve stimulator, transcutaneous stimulators will continue to generate maximum revenue.
In terms of end-users, hospitals will remain the largest segment, in terms of revenue and the trend is likely to continue through the forecast period. Outpatient centers, on the other hand, are expected to showcase limited revenue-generation possibilities.
"Given the applicability of peripheral nerve stimulators as a targeted alternative for pain management systems as opposed to high dosages of medication affecting the entire body, key companies manufacturing peripheral nerve stimulators are making substantial investments in clinical studies to improve the quality of treatment and technology for nerve disorder-related devices.
Advantages of peripheral nerve stimulator such as minimal or no side effects of administering neuromuscular blocking agents (NMBAs) along with integration of next-generation technology, is likely to shape the future of peripheral nerve stimulator", Senior Analyst, Persistence Market Research
Keeping A Tab On Key Players In The Peripheral Nerve Stimulators Market? Go To "Purchase Now" To Decipher The Competitive Analysis In Our Peripheral Nerve Stimulators Market Report! https://www.persistencemarketresearch.com/checkout/18982
PMR in its report on the global peripheral nerve stimulator landscape offers insights into the key developments and forward market strategies of top manufacturers of peripheral nerve stimulator. Companies are making novel innovations to specifically target peripheral nerve pain for patients who are not responsive to pharmacologic therapies. Key differentiation strategies adopted by key manufacturers include:
Tier-1 companies such as Boston Scientific Corporation, Vygon S.A, and ElectroCore, Inc. are likely to focus on expansion and acquisition strategies to further strengthen their market position. Boston Scientific Corporation, for instance, recently acquired BTG PLC to further expand its peripheral interventions portfolio with minimally invasive treatments for cancers and vascular conditions
Tier-2 companies including Medline Industries, Inc, NeuroSigma, Inc., Stimwave LLC will continue to focus on emerging markets for new product launches along with increasing their production capacity. Stimwave LLC, for instance, recently launched first wireless, micro-technology, and drug free neuromodulation device for relief from chronic pain.
Other smaller players are also projected to make acquisitions to expand their product and services platform, with a key focus on emerging markets in APEJ.
PMR also foresees substantial investments in R&D by companies and long-term contractual collaborations with research institutions.
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - email@example.com
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peripheral Nerve Stimulators Market Expected To Witness Sublimation With A CAGR Of 7.3% Between 2028 here
News-ID: 2700750 • Views: 386
More Releases from Persistence Market Research
The Subsequent Upcoming Years To See The Ostomy Drainage Bags Market Grow On A G …
As per Persistence Market Research's latest industry analysis, the global ostomy drainage bags market was valued at US$ 1.57 Bn in 2020, and is expected to exhibit a CAGR of around 3.5% over the forecast period (2021-2031). Ostomy drainage bags are useful for patients who suffer from chronic diseases such as irritable bowel syndrome, colorectal cancer, ulcerative colitis, Crohn's disease, diverticulitis, and others. Since the prevalence of these diseases has been
The Indwelling Catheters Market To Prove Its Servility To Technological Advancem …
According to a recent study by Persistence Market Research, the global indwelling catheters market is anticipated to witness high growth at 6.4% CAGR and be valued at over US$ 13.5 Bn by 2031. Demand for indwelling catheters is surging with increasing geriatric population. With increasing age, the immune system becomes weak and people become more prone to illnesses and suffer from different diseases such as cancer and kidney diseases. According to Population
The Subsequent Upcoming Years To See The Endodontic Reparative Cement Market Gro …
The global Endodontic Reparative Cement Market is expected to witness a CAGR of 4.2% and reach US$ 475.3 Mn by the year 2031. According to a recent study by Persistence Market Research, the global endodontic reparative cement market is expected to witness high growth from US$ 313.7 Mn in 2021 to US$ 475.3 Mn by 2031 at CAGR of around 4.2%. Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/20839 Growing number of endodontic procedures
Cancer Treatment Centers to Account for Over 90% CAR T-cell Therapy Market Share
The conventional practices are being augmented through robotic, AI-driven systems, thereby taking the past as well as the present to the future. This would, in the true sense, let clinicians carve cutting-edge technologies and implement them in proper ways, and avert the probable risks. This would be the scene with the CAR T-Cell Therapy Market in the upcoming decade. According to a recent study by Persistence Market Research, the global CAR
More Releases for Peripheral
PC Gaming Peripheral Market
PC Gaming Peripheral Market Research study which offers insights of in-depth research on historic and current market size along with the expected future prospects of the market and emerging trends in the market. The PC Gaming Peripheral Market report provides crucial information about the market, including Opinions from Industry experts, and the recent progressions and developments of the PC Gaming Peripheral Market. PC gaming peripheral are external hardware devices such as
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018
"The Report Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Diabetic Peripheral Neuropathy Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. "Diabetic neuropathy is nerve damage caused by diabetes. The type
Peripheral Intravenous Catheter Market
New research report offers a comprehensive analysis of the “Peripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021“The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Request to view Sample Report @ https://www.mrrse.com/sample/2827 Peripheral intravenous catheter is a sophisticated medical device widely used to
An Introduction to Peripheral Intervention Market
Peripheral intervention surgeries are part of the minimal invasive surgeries done to remove plaques, etc, thereby addressing the root cause of peripheral artery disease. Peripheral intervention surgeries restore the flow of blood to the other part of the arteries where the blood clot prevented the flow of oxygenated blood. These procedures require the use of a catheter, (which is a thin microfiber made of metal composites and polymers), these catheters
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy - Pipeline Review, H1 2017, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type of neuropathy occurring in the arms, hands, legs and feet is known as diabetic peripheral neuropathy. Symptoms include numbness or tingling in the feet pain or discomfort in the feet or legs-including prickly,